BatX Energies Pvt. Ltd. announced that it has received INR 410 million in funding from Zephyr Management, L.P., LetsVenture Online Pte. Ltd., JITO Angel Network, Mankind Pharma Limited, Excel Industries Limited, Blu-Smart Mobility Pvt Ltd and other investors
December 18, 2023
Share
BatX Energies Pvt. Ltd. announced that it has raised INR 410,000,000 in a round of funding led by new investor Zephyr Management, L.P. on December 19, 2023. The transaction included participation from new investor LetsVenture Online Pte.
Ltd. and returning investors JITO Angel Network (JAN), family offices of Mankind Pharma Limited, Excel Industries Limited and Blu-Smart Mobility Pvt Ltd and other investors.
Mankind Pharma Limited is an India-based pharmaceutical company. The Company is engaged in developing, manufacturing, and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products. It has a portfolio of formulations in several therapeutic areas, such as anti-infectives, cardiovascular, gastrointestinal, vitamins/minerals/nutrients, respiratory, anti-diabetic, dermatology, gynecology, and pain/analgesics, among others. Its other therapeutic areas include urology, ophthalmology, antiparasitic, stomatological, antineoplastic/immunomodulator, hepatoprotective, anti-malarial, blood-related, hormones, antiviral, sex stimulants/rejuvenators, anti-tuberculosis, parenteral and vaccines. Its portfolio of brands includes Nurokind, Telmikind, Manforce (Rx), Gudcef, Moxikind, Amlokind, Glimestar, Asthakind, Codistar, Candiforce, Mahacef, Dydroboon, Cefakind, Zenflox, Monticope, Dynaglipt, and others.
BatX Energies Pvt. Ltd. announced that it has received INR 410 million in funding from Zephyr Management, L.P., LetsVenture Online Pte. Ltd., JITO Angel Network, Mankind Pharma Limited, Excel Industries Limited, Blu-Smart Mobility Pvt Ltd and other investors
MANKIND PHARMA LIMITED 
